OBJECTIVE: The at-risk mental state (ARMS) is associated with a very high risk of psychosis, but it is difficult to predict which individuals will later develop psychosis on the basis of their presenting symptoms. We investigated psychopathological dimensions in subjects with an ARMS and examined whether particular symptom dimensions predicted subsequent transition to psychosis. METHOD: The sample comprised 122 subjects (aged 16-35 years) meeting Personal Assessment and Crisis Evaluation clinic criteria for the ARMS recruited through Outreach and Support in South London, a clinical service for people with an ARMS. A principal axis factor analysis was performed on symptom scores, obtained at presentation from the Comprehensive Assessment of the At-Risk Mental State, using Varimax rotation. The relationship between dimension scores and transition to psychosis during the following 24 months was then examined employing Cox regression analysis. RESULTS: Factor analysis gave rise to a 5-factor solution of negative, anxiety, disorganization/cognitive, self-harm, and manic symptom dimensions, accounting for 37% of the total variance. Scores on the negative and on the disorganization/cognitive dimensions were associated with transition to psychosis during the follow-up period (P = 0.044 and P = 0.005, respectively). CONCLUSION: The symptoms of the ARMS have a dimensional structure similar to that evident in patients with schizophrenia except for the positive symptom dimension. The association between scores on the disorganization/cognitive and negative dimensions and later transition is consistent with independent evidence that formal thought disorder, subjective cognitive impairments, and negative symptoms are linked to the subsequent onset of psychosis.
OBJECTIVE: The at-risk mental state (ARMS) is associated with a very high risk of psychosis, but it is difficult to predict which individuals will later develop psychosis on the basis of their presenting symptoms. We investigated psychopathological dimensions in subjects with an ARMS and examined whether particular symptom dimensions predicted subsequent transition to psychosis. METHOD: The sample comprised 122 subjects (aged 16-35 years) meeting Personal Assessment and Crisis Evaluation clinic criteria for the ARMS recruited through Outreach and Support in South London, a clinical service for people with an ARMS. A principal axis factor analysis was performed on symptom scores, obtained at presentation from the Comprehensive Assessment of the At-Risk Mental State, using Varimax rotation. The relationship between dimension scores and transition to psychosis during the following 24 months was then examined employing Cox regression analysis. RESULTS: Factor analysis gave rise to a 5-factor solution of negative, anxiety, disorganization/cognitive, self-harm, and manic symptom dimensions, accounting for 37% of the total variance. Scores on the negative and on the disorganization/cognitive dimensions were associated with transition to psychosis during the follow-up period (P = 0.044 and P = 0.005, respectively). CONCLUSION: The symptoms of the ARMS have a dimensional structure similar to that evident in patients with schizophrenia except for the positive symptom dimension. The association between scores on the disorganization/cognitive and negative dimensions and later transition is consistent with independent evidence that formal thought disorder, subjective cognitive impairments, and negative symptoms are linked to the subsequent onset of psychosis.
Authors: R Smieskova; P Fusar-Poli; P Allen; K Bendfeldt; R D Stieglitz; J Drewe; E W Radue; P K McGuire; A Riecher-Rössler; S J Borgwardt Journal: Neurosci Biobehav Rev Date: 2010-02-06 Impact factor: 8.989
Authors: Stephan Ruhrmann; Frauke Schultze-Lutter; Raimo K R Salokangas; Markus Heinimaa; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson; Georg Juckel; Andreas Heinz; Anthony Morrison; Shôn Lewis; Heinrich Graf von Reventlow; Joachim Klosterkötter Journal: Arch Gen Psychiatry Date: 2010-03
Authors: A Demjaha; K Morgan; C Morgan; S Landau; K Dean; A Reichenberg; P Sham; P Fearon; G Hutchinson; P B Jones; R M Murray; P Dazzan Journal: Psychol Med Date: 2009-07-23 Impact factor: 7.723
Authors: Tyrone D Cannon; Kristin Cadenhead; Barbara Cornblatt; Scott W Woods; Jean Addington; Elaine Walker; Larry J Seidman; Diana Perkins; Ming Tsuang; Thomas McGlashan; Robert Heinssen Journal: Arch Gen Psychiatry Date: 2008-01
Authors: Gregory P Strauss; Andrea Pelletier-Baldelli; Katherine Frost Visser; Elaine F Walker; Vijay A Mittal Journal: Schizophr Res Date: 2020-06-07 Impact factor: 4.939
Authors: Barbara A Cornblatt; Ricardo E Carrión; Andrea Auther; Danielle McLaughlin; Ruth H Olsen; Majnu John; Christoph U Correll Journal: Am J Psychiatry Date: 2015-06-05 Impact factor: 18.112
Authors: C M Corcoran; J G Keilp; J Kayser; C Klim; P D Butler; G E Bruder; R C Gur; D C Javitt Journal: Psychol Med Date: 2015-06-04 Impact factor: 7.723
Authors: Paola Dazzan; Bridget Soulsby; Andrea Mechelli; Stephen J Wood; Dennis Velakoulis; Lisa J Phillips; Alison R Yung; Xavier Chitnis; Ashleigh Lin; Robin M Murray; Patrick D McGorry; Philip K McGuire; Christos Pantelis Journal: Schizophr Bull Date: 2011-04-25 Impact factor: 9.306
Authors: Cheryl M Corcoran; Vijay A Mittal; Carrie E Bearden; Raquel E Gur; Kasia Hitczenko; Zarina Bilgrami; Aleksandar Savic; Guillermo A Cecchi; Phillip Wolff Journal: Schizophr Res Date: 2020-06-01 Impact factor: 4.939
Authors: Nella Lo Cascio; Riccardo Saba; Marta Hauser; Ditte Lammers Vernal; Aseel Al-Jadiri; Yehonatan Borenstein; Eva M Sheridan; Taishiro Kishimoto; Marco Armando; Stefano Vicari; Paolo Fiori Nastro; Paolo Girardi; Eva Gebhardt; John M Kane; Andrea Auther; Ricardo E Carrión; Barbara A Cornblatt; Benno G Schimmelmann; Frauke Schultze-Lutter; Christoph U Correll Journal: Eur Child Adolesc Psychiatry Date: 2016-02-26 Impact factor: 4.785
Authors: Mart L J M Eussen; Esther I de Bruin; Arthur R Van Gool; Anneke Louwerse; Jan van der Ende; Fop Verheij; Frank C Verhulst; Kirstin Greaves-Lord Journal: Eur Child Adolesc Psychiatry Date: 2014-05-10 Impact factor: 4.785